Clinical Trial Update: Clofarabine, Cytarabine, and Filgrastim in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia, Advanced Myelodysplastic Syndrome, and/or Advanced Myeloproliferative Neoplasm [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the combination of Clofarabine, Cytarabine, and Filgrastim in adults with newly diagnosed acute myeloid leukemia and related m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia with
• Acute Myeloid Leukemia with Deletion of 5q
• Acute Myeloid Leukemia with Inv
• Acute Myeloid Leukemia with Mll Rearrangement
• Myelodysplastic Syndrome De Novo
• Myelomonocytic Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Clolar (Clofarabine)
• Neupogen (Filgrastim)

Snippet

Sponsor: University of Washington | Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q) | Phase 2 | Status: COMPLETED | Results posted: 2017-10-19